Sarcoma of the UterusGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)

Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Fehr M, Follmann M, Haase H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Thiel F, Ulrich UA, Vogl T, Vordermark D, Wallwiener M, Gaß P, Beckmann M (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 82

Pages Range: 1337-1367

Journal Issue: 12

DOI: 10.1055/a-1897-5124

Abstract

Purpose This is an official guideline, published and coordinated by the Germany Society for Gynecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG). Because of their rarity and heterogeneous histopathology, uterine sarcomas are challenging in terms of their clinical management and therefore require a multidisciplinary approach. To our knowledge, there are currently no binding evidence-based recommendations for the appropriate management of this heterogeneous group of tumors. Methods This S2k guideline was first published in 2015. The update published here is once again the result of the consensus of a representative interdisciplinary committee of experts who were commissioned by the Guidelines Committee of the DGGG to carry out a systematic search of the literature on uterine sarcomas. Members of the participating professional societies achieved a formal consensus after a structured consensus process. Recommendations 1.1 Epidemiology, classification, staging of uterine sarcomas. 1.2 Symptoms, general diagnostic workup, general pathology or genetic predisposition to uterine sarcomas. 2. Management of leiomyosarcomas. 3. Management of low-grade endometrial stromal sarcomas. 4. Management of high-grade endometrial stromal sarcoma and undifferentiated uterine sarcomas. 5. Management of adenosarcomas. 6. Rhabdomyosarcomas of the uterus in children and adolescents. 7. Follow-up of uterine sarcomas. 8. Management of morcellated uterine sarcomas. 9. Information provided to patients.

Authors with CRIS profile

Involved external institutions

Universitätsklinikum Heidelberg Germany (DE) Universitätsklinikum Bonn Germany (DE) Hochtaunus-Kliniken Germany (DE) MVZ für Histologie, Zytologie und Molekulare Diagnostik Germany (DE) Kantonsspital Frauenfeld Switzerland (CH) Universitätsmedizin Greifswald / Universitätsklinikum Greifswald Germany (DE) Universitätsklinikum Köln Germany (DE) Universitätsklinikum Halle (Saale) Germany (DE) Frauenselbsthilfe nach Krebs - Bundesverband e. V. Germany (DE) Städtisches Klinikum Karlsruhe Germany (DE) Medizinische Universität Graz Austria (AT) Kliniken Essen-Mitte Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) Germany (DE) Universitätsklinikum Leipzig Germany (DE) Alb Fils Kliniken Germany (DE) Universitätsklinikum Ulm Germany (DE) Martin-Luther-Krankenhaus Germany (DE) Universitätsklinikum Freiburg Germany (DE) Deutsche Krebsgesellschaft (DKG) Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz Germany (DE) Klinikum Augsburg Germany (DE) Klinikum Darmstadt Germany (DE) Berufsverband der Frauenärzte e.V. Germany (DE) HELIOS Kliniken Germany (DE)

How to cite

APA:

Denschlag, D., Ackermann, S., Battista, M.J., Cremer, W., Egerer, G., Fehr, M.,... Beckmann, M. (2022). Sarcoma of the UterusGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021). Geburtshilfe und Frauenheilkunde, 82(12), 1337-1367. https://doi.org/10.1055/a-1897-5124

MLA:

Denschlag, Dominik, et al. "Sarcoma of the UterusGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)." Geburtshilfe und Frauenheilkunde 82.12 (2022): 1337-1367.

BibTeX: Download